About Intellectual Property IP Training Respect for IP IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships AI Tools & Services The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars IP Enforcement WIPO ALERT Raising Awareness World IP Day WIPO Magazine Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Webcast WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO Translate Speech-to-Text Classification Assistant Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight
Arabic English Spanish French Russian Chinese
Laws Treaties Judgments Browse By Jurisdiction

Decree on the Legal Protection of Biotechnological Inventions, Slovenia

Back
Latest Version in WIPO Lex
Details Details Year of Version 2003 Dates Entry into force: September 2, 2003 Type of Text Implementing Rules/Regulations Subject Matter Patents (Inventions)

Available Materials

Main Text(s) Related Text(s)
Main text(s) Main text(s) English Decree on the Legal Protection of Biotechnological Inventions        

On the basis of the second paragraph of Article 10 of the Industrial Property Act (Official

Gazette of the Republic of Slovenia, No. 7/03), the Government of the Republic of Slovenia

hereby issues the following

DECREE 1

ON THE LEGAL PROTECTION OF BIOTECHNOLOGICAL INVENTIONS

Article 1

This Decree defines detailed conditions for the grant of patents for biotechnological

inventions, which have to be fulfilled beside those prescribed by the Industrial Property Act.

Article 2

(1) For the purposes of this Decree,

(a) “biological material” means any material containing genetic information and capable of

reproducing itself or being reproduced in a biological system;

(b) “microbiological process” means any process involving or performed upon or resulting in

microbiological material.

(2) A process for the production of plants or animals is essentially biological if it consists

entirely of natural phenomena such as crossing or selection.

(3) “Variety” shall be taken to mean a plant grouping within a single botanical taxon of the

lowest known rank, which grouping, irrespective of whether the conditions for the grant of a

plant variety right are fully met, can be:

(a) defined by the expression of the characteristics that results from a given genotype or

combination of genotypes,

(b) distinguished from any other plant grouping by the expression of at least one of the said

characteristics, and

(c) considered as a unit with regard to its suitability for being propagated unchanged.

Article 3

(1) For the purposes of this Decree, inventions which are new, which involve an inventive

step and which are susceptible of industrial application shall be patentable even if they

concern a product consisting of or containing biological material or a process by means of

which biological material is produced, processed or used.

1 Published in the Official Gazette RS, No. 81/03. Entry into force: 2 September 2003.

(2) Biological material which is isolated from its natural environment or produced by means

of a technical process may be the subject of an invention even if it previously occurred in

nature.

Article 4

(1) The following shall not be patentable:

(a) plant and animal varieties; and

(b) essentially biological processes for the production of plants or animals.

(2) Inventions which concern plants or animals shall be patentable if the technical feasibility

of the invention is not confined to a particular plant or animal variety.

(3) Paragraph 1(b) shall be without prejudice to the patentability of inventions which concern

a microbiological or other technical process or a product obtained by means of such a process.

Article 5

(1) The human body, at the various stages of its formation and development, and the simple

discovery of one of its elements, including the sequence or partial sequence of a gene, cannot

constitute patentable inventions.

(2) An element isolated from the human body or otherwise produced by means of a technical

process, including the sequence or partial sequence of a gene, may constitute a patentable

invention, even if the structure of that element is identical to that of a natural element.

(3) The industrial application of a sequence or a partial sequence of a gene must be disclosed

in the patent application.

Article 6

(1) Inventions shall be considered unpatentable where their commercial exploitation would be

contrary to ordre public or morality; however, exploitation shall not be deemed to be so

contrary merely because it is prohibited by law or regulation.

(2) On the basis of paragraph 1, the following, in particular, shall be considered unpatentable:

(a) processes for cloning human beings;

(b) processes for modifying the germ line genetic identity of human beings;

(c) uses of human embryos for industrial or commercial purposes;

(d) processes for modifying the genetic identity of animals which are likely to cause them

suffering without any substantial medical benefit to man or animal, and also animals resulting

from such processes.

Article 7

(1) The protection conferred by a patent on a biological material possessing specific

characteristics as a result of the invention shall extend to any biological material derived from

that biological material through propagation or multiplication in an identical or divergent

form and possessing those same characteristics.

(2) The protection conferred by a patent on a process that enables a biological material to be

produced possessing specific characteristics as a result of the invention shall extend to

biological material directly obtained through that process and to any other biological material

derived from the directly obtained biological material through propagation or multiplication in

an identical or divergent form and possessing those same characteristics.

Article 8

The protection conferred by a patent on a product containing or consisting of genetic

information shall extend to all material, save as provided in Article 5(1), in which the product

in incorporated and in which the genetic information is contained and performs its function.

Article 9

The protection referred to in Articles 7 and 8 shall not extend to biological material obtained

from the propagation or multiplication of biological material placed on the market in the

territory of the Republic of Slovenia by the holder of the patent or with his consent, where the

multiplication or propagation necessarily results from the application for which the biological

material was marketed, provided that the material obtained is not subsequently used for other

propagation or multiplication.

Article 10

(1) By way of derogation from Articles 7 and 8, the sale or other form of commercialisation

of plant propagating material to a farmer by the holder of the patent or with his consent for

agricultural use implies authorisation for the farmer to use the product of his harvest,

according to Article 16 of the Protection of New Plant Varieties Act, for propagation or

multiplication by him on his own farm.

(2) By way of derogation from Articles 7 and 8, the sale or any other form of

commercialisation of breeding stock or other animal reproductive material to a farmer by the

holder of the patent or with his consent implies authorisation for the farmer to use the

protected livestock for an agricultural purpose. This includes making the animal or other

animal reproductive material available for the purposes of pursuing his agricultural activity

but not sale within the framework or for the purpose of a commercial reproduction activity.

Article 11

(1) Where a breeder cannot acquire or exploit a plant variety right without infringing a prior

patent, he may apply for a compulsory licence for non-exclusive use of the invention

protected by the patent inasmuch as the licence is necessary for the exploitation of the plant

variety to be protected, subject to payment of an appropriate royalty.

(2) Where the holder of a patent concerning a biotechnological invention cannot exploit it

without infringing a prior plant variety right, he may apply for a compulsory licence for non-

exclusive use of the plant variety protected by that right, subject to payment of an appropriate

royalty.

(3) Applicants for the licences referred to in paragraphs 1 and 2 must demonstrate that:

(a) they have applied unsuccessfully to the holder of the patent or of the plant variety right to

obtain a contractual licence;

(b) the plant variety or the invention constitutes significant technical progress of considerable

economic interest compared with the invention claimed in the patent or the protected plant

variety.

Article 12

Applications for patents for biotechnological inventions which were filed before the date of

entry into force of this Decree shall be treated in accordance with the provisions of this

Decree.

Article 13

This Decree shall enter into force on the fifteenth day following its publication in the Official

Gazette of the Republic of Slovenia.


No data available.

WIPO Lex No. SI034